Availability of point-of-care HBV tests in resource-limited settings.

Lau DTY, Jackson K, Picchio CA, Kramvis A, Sonderup M, Lemoine M, Matthews G, Howell J, Coffin CS, Hellard M, Lee AU, Anderson DA, Kerth HA, Lee EE, Tavis JE, Dandri M, Revill PA, Spearman CW, Penicaud C, Levrero M, El-Sayed M, ICE-HBV POC Model in Resource Limited Settings working group

Hepatitis B

Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol.

Doyle JS, Heath K, Elsum I, Douglass C, Wade A, Kasza J, Allardice K, Von Bibra S, Chan K, Camesella B, Guzman R, Bryant M, Thompson AJ, Stoové MA, Snelling TL, Scott N, Spelman T, Anderson D, Richmond J, Howell J, Andric N, Dietze PM, Higgs P, Sacks-Davis R, Forbes AB, Hellard ME, Pedrana AE

Hepatitis C

Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016-2022: an observational program evaluation.

Causer LM, Ward J, Smith K, Saha A, Andrewartha K, Wand H, Hengel B, Badman SG, Tangey A, Matthews S, Mak D, Gunathilake M, Moore E, Speers D, Persing D, Anderson D, Whiley D, Maher L, Regan D, Donovan B, Fairley C, Kaldor J, Shephard M, Guy R, TTANGO2 Collaboration

Sexually Transmitted Infections (STI's)

Novel point-of-care cytokine biomarker lateral flow test for the screening for sexually transmitted infections and bacterial vaginosis: study protocol of a multicentre multidisciplinary prospective observational clinical study to evaluate the performance and feasibility of the Genital InFlammation Test (GIFT).

Ramboarina S, Crucitti T, Gill K, Bekker LG, Harding-Esch EM, van de Wijgert JHHM, Huynh BT, Fortas C, Harimanana A, Mayouya Gamana T, Randremanana RV, Mangahasimbola R, Dziva Chikwari C, Kranzer K, Mackworth-Young CRS, Bernays S, Thomas N, Anderson D, Tanko FR, Manhanzva M, Lurie M, Khumalo F, Sinanovic E, Honda A, Pidwell T, Francis SC, Masson L, Passmore JA, GIFT study group

Sexual + Reproductive Health Sexually Transmitted Infections (STI's)

Dimeric immunoglobulin A as a novel diagnostic marker of measles infection.

Mohd Hanafiah K, Hiebert J, Zubach V, Severini A, Anderson DA, Drummer HE.

Global Infectious Disease Threats

Serological assays to measure dimeric IgA antibodies in SARS-CoV-2 infections.

Wei Z, Angrisano F, Eriksson EM, Mazhari R, Van H, Zheng S, Center RJ, Boo I, McMahon J, Lau J, Kiernan-Walker N, Ruybal-Pesántez S, Mueller I, Robinson LJ, Anderson DA, Drummer HE

COVID-19